Effect of BMS-650032 on the Pharmacokinetics of a Combined Oral Contraceptive Containing Ethinyl Estradiol and Norgestimate (Ortho Tri- Cyclen (R)) in Healthy Female Subjects.
Phase of Trial: Phase I
Latest Information Update: 15 Jul 2010
At a glance
- Drugs Asunaprevir; Ethinylestradiol/norgestimate
- Indications Hepatitis C; Menopausal syndrome; Pregnancy
- Focus Pharmacokinetics
- 29 Jun 2010 Actual patient number (17) added as reported by ClinicalTrials.gov.
- 29 Jun 2010 Actual end date added to 1 Jun 2010 as reported by ClinicalTrials.gov.
- 29 Jun 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.